(ELDN) – Equity Offerings
-
Eledon Pharmaceuticals (ELDN) Announces 75.76M Share Offering by Selling Stockholders
-
Eledon Pharmaceuticals (ELDN) Announces up to $185M Financing to Advance Tegoprubart Kidney Transplantation Clinical Trials
Back to ELDN Stock Lookup